Nukkleus Inc
NUKK4.420USD
-0.170-3.70%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
49.05MMarket Cap
LossP/E TTM
More Details of Nukkleus Inc Company
Nukkleus Inc. is a financial technology company. The Company is focused on providing software and technology solutions for the worldwide retail foreign exchange (FX) trading industry. The Company primarily provides its software, technology, customer sales and marketing and risk management technology hardware and software solutions package to Triton Capital Markets Ltd. Its technology Nukkleus Tech is an advanced trading technology platform for dealing and risk management with global liquidity and customizable leveraging and enables customers to have control over their trading quote and liquidity strategies. Its digital RFQ is a digital asset execution service providing global counterparts with access to global liquidity and a suite of institutional products and services. It offers blockchain-enabled financial services solutions that are secure, compliant, and globally accessible offering crypto enabled payments and transfers as well as digital asset trading and brokerage.
Nukkleus Inc Info
Ticker SymbolNUKK
Company nameNukkleus Inc
IPO dateFeb 08, 2021
CEOShalom (Menachem)
Number of employees14
Security typeOrdinary Share
Fiscal year-endFeb 08
Address575 Fifth Avenue, 14Th Floor
CityNEW YORK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code10017
Phone12127914663
Websitehttps://www.nukk.com
Ticker SymbolNUKK
IPO dateFeb 08, 2021
CEOShalom (Menachem)
Company Executives of Nukkleus Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Menachem Shalom
Mr. Menachem Shalom
Chief Executive Officer, Director
Chief Executive Officer, Director
1.25M
+150.00%
Mr. Reuven Yeganeh
Mr. Reuven Yeganeh
Independent Director
Independent Director
20.00K
+100.00%
Mr. Tomer Nagar
Mr. Tomer Nagar
Independent Director
Independent Director
15.00K
+50.00%
Mr. David Rokach
Mr. David Rokach
Independent Director
Independent Director
15.00K
+50.00%
Ms. Aviya Volodarsky
Ms. Aviya Volodarsky
Independent Director
Independent Director
15.00K
+50.00%
Ms. Anastasiia Kotaieva
Ms. Anastasiia Kotaieva
Director
Director
--
-100.00%
Mr. Morel Levi
Mr. Morel Levi
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lena Cati
Ms. Lena Cati
Investor Relations
Investor Relations
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Menachem Shalom
Mr. Menachem Shalom
Chief Executive Officer, Director
Chief Executive Officer, Director
1.25M
+150.00%
Mr. Reuven Yeganeh
Mr. Reuven Yeganeh
Independent Director
Independent Director
20.00K
+100.00%
Mr. Tomer Nagar
Mr. Tomer Nagar
Independent Director
Independent Director
15.00K
+50.00%
Mr. David Rokach
Mr. David Rokach
Independent Director
Independent Director
15.00K
+50.00%
Ms. Aviya Volodarsky
Ms. Aviya Volodarsky
Independent Director
Independent Director
15.00K
+50.00%
Ms. Anastasiia Kotaieva
Ms. Anastasiia Kotaieva
Director
Director
--
-100.00%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2024
FY2023
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
Malta
4.80M
81.17%
Rest of the world
1.11M
18.83%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, Nov 20
Updated: Thu, Nov 20
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
X Group Family of Funds Limited Partnership
7.93%
Shalom (Menachem)
7.51%
Assentato (Emil Flemming)
4.03%
BlackRock Institutional Trust Company, N.A.
2.08%
The Vanguard Group, Inc.
0.72%
Other
77.73%
Shareholders
Shareholders
Proportion
X Group Family of Funds Limited Partnership
7.93%
Shalom (Menachem)
7.51%
Assentato (Emil Flemming)
4.03%
BlackRock Institutional Trust Company, N.A.
2.08%
The Vanguard Group, Inc.
0.72%
Other
77.73%
Shareholder Types
Shareholders
Proportion
Individual Investor
11.93%
Corporation
7.93%
Investment Advisor
3.42%
Investment Advisor/Hedge Fund
0.66%
Bank and Trust
0.20%
Research Firm
0.03%
Hedge Fund
0.01%
Other
75.82%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
45
291.49K
2.15%
+76.09K
2025Q2
48
2.12M
39.56%
-329.66K
2025Q1
50
2.63M
77.83%
-447.08K
2024Q4
47
3.32M
120.71%
+1.83M
2024Q3
37
977.71K
38.15%
-90.56K
2024Q2
41
1.05M
60.58%
+629.37K
2024Q1
37
209.69K
75.50%
-281.75K
2023Q4
43
226.68K
83.09%
-326.16K
2023Q3
40
223.97K
92.89%
-403.87K
2023Q2
41
225.34K
93.41%
-398.24K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
X Group Family of Funds Limited Partnership
469.95K
6.64%
--
--
Jul 25, 2025
Shalom (Menachem)
500.00K
7.07%
--
--
Jul 25, 2025
Assentato (Emil Flemming)
671.19K
9.49%
--
--
Jul 25, 2025
BlackRock Institutional Trust Company, N.A.
9.16K
0.13%
+5.52K
+151.48%
Jun 30, 2025
The Vanguard Group, Inc.
50.33K
0.71%
+11.55K
+29.80%
Jun 30, 2025
UBS Financial Services, Inc.
63.04K
0.89%
+46.20K
+274.39%
Jun 30, 2025
Geode Capital Management, L.L.C.
31.02K
0.44%
+1.05K
+3.49%
Jun 30, 2025
Northern Trust Investments, Inc.
11.86K
0.17%
+11.86K
--
Jun 30, 2025
UBS Switzerland AG
2.25K
0.03%
+1.80K
+400.00%
Jun 30, 2025
Hightower Advisors, LLC
11.70K
0.17%
+11.70K
--
Jun 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Oct 18, 2024
Merger
8→1
Oct 18, 2024
Merger
8→1
Oct 18, 2024
Merger
8→1
Oct 18, 2024
Merger
8→1
Date
Type
Ratio
Oct 18, 2024
Merger
8→1
Oct 18, 2024
Merger
8→1
Oct 18, 2024
Merger
8→1
Oct 18, 2024
Merger
8→1
FAQs
Who are the top five shareholders of Nukkleus Inc?
The top five shareholders of Nukkleus Inc are:
X Group Family of Funds Limited Partnership holds 469.95K shares, accounting for 6.64% of the total shares.
Shalom (Menachem) holds 500.00K shares, accounting for 7.07% of the total shares.
Assentato (Emil Flemming) holds 671.19K shares, accounting for 9.49% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 9.16K shares, accounting for 0.13% of the total shares.
The Vanguard Group, Inc. holds 50.33K shares, accounting for 0.71% of the total shares.
X Group Family of Funds Limited Partnership holds 469.95K shares, accounting for 6.64% of the total shares.
Shalom (Menachem) holds 500.00K shares, accounting for 7.07% of the total shares.
Assentato (Emil Flemming) holds 671.19K shares, accounting for 9.49% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 9.16K shares, accounting for 0.13% of the total shares.
The Vanguard Group, Inc. holds 50.33K shares, accounting for 0.71% of the total shares.
What are the top three shareholder types of Nukkleus Inc?
The top three shareholder types of Nukkleus Inc are:
X Group Family of Funds Limited Partnership
Shalom (Menachem)
Assentato (Emil Flemming)
X Group Family of Funds Limited Partnership
Shalom (Menachem)
Assentato (Emil Flemming)
How many institutions hold shares of Nukkleus Inc (NUKK)?
As of 2025Q3, 45 institutions hold shares of Nukkleus Inc, with a combined market value of approximately 291.49K, accounting for 2.15% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -37.41%.
What is the biggest source of revenue for Nukkleus Inc?
In FY2024, the -- business generated the highest revenue for Nukkleus Inc, amounting to -- and accounting for --% of total revenue.
